Drug Interactions

Drug interactions between abacavir and Aptivus

Results for the following 2 drugs:

abacavir
Aptivus (tipranavir)

Interactions between your selected drugs

abacavir ⇔ tipranavir

Applies to: abacavir and Aptivus (tipranavir)

MONITOR: Coadministration with tipranavir in combination with low-dose ritonavir may decrease the plasma concentrations of abacavir. The mechanism of interaction is unknown. In 53 HIV-positive subjects, three different regimens of tipranavir/ritonavir (250 mg/200 mg; 750 mg/100 mg; and 1250 mg/100 mg twice a day for 21 days) decreased the mean peak plasma concentration (Cmax) and area under the plasma concentration-time curve (AUC) of steady-state abacavir (300 mg twice a day) by approximately 50% and 40%, respectively, compared to administration of abacavir without tipranavir/ritonavir. The clinical significance of these changes is unknown.

MANAGEMENT: Antiretroviral response should be monitored closely when tipranavir/ritonavir is used in combination with abacavir. Currently, there are no dosage adjustment recommendations available for abacavir when prescribed with tipranavir/ritonavir.

See also...




Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement

(web3)